When immune cells strike, precision is everything. New research reveals how natural killer and T cells orchestrate the ...

In this thesis, we have investigated a specific type of T cell, the γδT cell, and its potential as an immunotherapy against cancer. We aimed to improve current γδT cell-based therapies and demonstrate ...

Scientists have found a way to transform hard-to-treat tumors into targets for the immune system. Using two protein stimulators, they activated strong T-cell and B-cell responses and built immune ...

The evolution of immunotherapy, featuring CAR-T cells and senolytics, highlights potential in cancer treatment and challenges ...

Johns Hopkins scientists discovered a way to convert “immune-cold” tumors into “immune-hot” ones by activating key immune ...

Killer immune cells destroy cancer cells and cells infected by virus. These CD8 + T cells are activated after detection of viral infection or growth of “non-self” tumor cells. However, in chronic ...

Chimeric antigen receptor (CAR) T cell therapy, which uses a patient's own immune cells to fight cancer, has emerged as a powerful way to treat lymphoma and other blood cancers. But researchers have ...

Bryn Ailinger had a rare mutation that made her leukemia less responsive to tradition treatment. But CAR T-Cell therapy ...

New research found that gene therapy for children with a form of severe combined immunodeficiency was successful in 95% of ...

When Los Angeles anesthesiologist Dr. Nick Mondek learned his leukemia had returned earlier this year, he feared his options were running out.